An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease.
cam.issuedOnline | 2021-12 | |
dc.contributor.author | Peng, Yanchun | |
dc.contributor.author | Felce, Suet Ling | |
dc.contributor.author | Dong, Danning | |
dc.contributor.author | Penkava, Frank | |
dc.contributor.author | Mentzer, Alexander J | |
dc.contributor.author | Yao, Xuan | |
dc.contributor.author | Liu, Guihai | |
dc.contributor.author | Yin, Zixi | |
dc.contributor.author | Chen, Ji-Li | |
dc.contributor.author | Lu, Yongxu | |
dc.contributor.author | Wellington, Dannielle | |
dc.contributor.author | Wing, Peter AC | |
dc.contributor.author | Dominey-Foy, Delaney CC | |
dc.contributor.author | Jin, Chen | |
dc.contributor.author | Wang, Wenbo | |
dc.contributor.author | Hamid, Megat Abd | |
dc.contributor.author | Fernandes, Ricardo A | |
dc.contributor.author | Wang, Beibei | |
dc.contributor.author | Fries, Anastasia | |
dc.contributor.author | Zhuang, Xiaodong | |
dc.contributor.author | Ashley, Neil | |
dc.contributor.author | Rostron, Timothy | |
dc.contributor.author | Waugh, Craig | |
dc.contributor.author | Sopp, Paul | |
dc.contributor.author | Hublitz, Philip | |
dc.contributor.author | Beveridge, Ryan | |
dc.contributor.author | Tan, Tiong Kit | |
dc.contributor.author | Dold, Christina | |
dc.contributor.author | Kwok, Andrew J | |
dc.contributor.author | Rich-Griffin, Charlotte | |
dc.contributor.author | Dejnirattisa, Wanwisa | |
dc.contributor.author | Liu, Chang | |
dc.contributor.author | Kurupati, Prathiba | |
dc.contributor.author | Nassiri, Isar | |
dc.contributor.author | Watson, Robert A | |
dc.contributor.author | Tong, Orion | |
dc.contributor.author | Taylor, Chelsea A | |
dc.contributor.author | Kumar Sharma, Piyush | |
dc.contributor.author | Sun, Bo | |
dc.contributor.author | Curion, Fabiola | |
dc.contributor.author | Revale, Santiago | |
dc.contributor.author | Garner, Lucy C | |
dc.contributor.author | Jansen, Kathrin | |
dc.contributor.author | Ferreira, Ricardo C | |
dc.contributor.author | Attar, Moustafa | |
dc.contributor.author | Fry, Jeremy W | |
dc.contributor.author | Russell, Rebecca A | |
dc.contributor.author | COMBAT Consortium | |
dc.contributor.author | Stauss, Hans J | |
dc.contributor.author | James, William | |
dc.contributor.author | Townsend, Alain | |
dc.contributor.author | Ho, Ling-Pei | |
dc.contributor.author | Klenerman, Paul | |
dc.contributor.author | Mongkolsapaya, Juthathip | |
dc.contributor.author | Screaton, Gavin R | |
dc.contributor.author | Dendrou, Calliope | |
dc.contributor.author | Sansom, Stephen N | |
dc.contributor.author | Bashford-Rogers, Rachael | |
dc.contributor.author | Chain, Benny | |
dc.contributor.author | Smith, Geoffrey L | |
dc.contributor.author | McKeating, Jane A | |
dc.contributor.author | Fairfax, Benjamin P | |
dc.contributor.author | Bowness, Paul | |
dc.contributor.author | McMichael, Andrew J | |
dc.contributor.author | Ogg, Graham | |
dc.contributor.author | Knight, Julian C | |
dc.contributor.author | Dong, Tao | |
dc.contributor.orcid | Peng, Yanchun [0000-0003-2340-0499] | |
dc.contributor.orcid | Penkava, Frank [0000-0001-9163-8576] | |
dc.contributor.orcid | Mentzer, Alexander J [0000-0002-4502-2209] | |
dc.contributor.orcid | Yin, Zixi [0000-0002-2044-5838] | |
dc.contributor.orcid | Wing, Peter AC [0000-0002-2354-3281] | |
dc.contributor.orcid | Fries, Anastasia [0000-0003-1609-5991] | |
dc.contributor.orcid | Zhuang, Xiaodong [0000-0002-6870-9003] | |
dc.contributor.orcid | Hublitz, Philip [0000-0001-8810-3247] | |
dc.contributor.orcid | Tan, Tiong Kit [0000-0001-8746-8308] | |
dc.contributor.orcid | Kwok, Andrew J [0000-0001-8928-5054] | |
dc.contributor.orcid | Rich-Griffin, Charlotte [0000-0001-8212-9542] | |
dc.contributor.orcid | Tong, Orion [0000-0002-0659-5944] | |
dc.contributor.orcid | Kumar Sharma, Piyush [0000-0002-6247-3503] | |
dc.contributor.orcid | Sun, Bo [0000-0002-5507-6657] | |
dc.contributor.orcid | Garner, Lucy C [0000-0002-6461-252X] | |
dc.contributor.orcid | Jansen, Kathrin [0000-0002-3803-7680] | |
dc.contributor.orcid | Attar, Moustafa [0000-0003-4116-1276] | |
dc.contributor.orcid | Fry, Jeremy W [0000-0003-3689-6606] | |
dc.contributor.orcid | Russell, Rebecca A [0000-0002-6517-6483] | |
dc.contributor.orcid | Stauss, Hans J [0000-0003-4340-7911] | |
dc.contributor.orcid | James, William [0000-0002-2506-1198] | |
dc.contributor.orcid | Klenerman, Paul [0000-0003-4307-9161] | |
dc.contributor.orcid | Mongkolsapaya, Juthathip [0000-0003-3416-9480] | |
dc.contributor.orcid | Screaton, Gavin R [0000-0002-3549-4309] | |
dc.contributor.orcid | Sansom, Stephen N [0000-0003-4569-8513] | |
dc.contributor.orcid | Bashford-Rogers, Rachael [0000-0002-6838-0711] | |
dc.contributor.orcid | Chain, Benny [0000-0002-7417-3970] | |
dc.contributor.orcid | Smith, Geoffrey L [0000-0002-3730-9955] | |
dc.contributor.orcid | Bowness, Paul [0000-0003-4597-0484] | |
dc.contributor.orcid | Dong, Tao [0000-0003-3545-3758] | |
dc.date.accessioned | 2022-01-06T11:50:04Z | |
dc.date.available | 2022-01-06T11:50:04Z | |
dc.date.issued | 2022-01 | |
dc.date.submitted | 2021-07-19 | |
dc.date.updated | 2022-01-06T11:50:03Z | |
dc.description | Funder: RCUK | Medical Research Council (MRC); doi: https://doi.org/10.13039/501100000265 | |
dc.description | Funder: Chinese Academy of Medical Sciences (CAMS); doi: https://doi.org/10.13039/501100005150 | |
dc.description | Funder: Wellcome Trust (Wellcome); doi: https://doi.org/10.13039/100004440 | |
dc.description.abstract | NP105-113-B*07:02-specific CD8+ T cell responses are considered among the most dominant in SARS-CoV-2-infected individuals. We found strong association of this response with mild disease. Analysis of NP105-113-B*07:02-specific T cell clones and single-cell sequencing were performed concurrently, with functional avidity and antiviral efficacy assessed using an in vitro SARS-CoV-2 infection system, and were correlated with T cell receptor usage, transcriptome signature and disease severity (acute n = 77, convalescent n = 52). We demonstrated a beneficial association of NP105-113-B*07:02-specific T cells in COVID-19 disease progression, linked with expansion of T cell precursors, high functional avidity and antiviral effector function. Broad immune memory pools were narrowed postinfection but NP105-113-B*07:02-specific T cells were maintained 6 months after infection with preserved antiviral efficacy to the SARS-CoV-2 Victoria strain, as well as Alpha, Beta, Gamma and Delta variants. Our data show that NP105-113-B*07:02-specific T cell responses associate with mild disease and high antiviral efficacy, pointing to inclusion for future vaccine design. | |
dc.identifier.doi | 10.17863/CAM.79594 | |
dc.identifier.eissn | 1529-2916 | |
dc.identifier.issn | 1529-2908 | |
dc.identifier.other | s41590-021-01084-z | |
dc.identifier.other | 1084 | |
dc.identifier.uri | https://www.repository.cam.ac.uk/handle/1810/332148 | |
dc.language | en | |
dc.language.iso | eng | |
dc.publisher | Springer Science and Business Media LLC | |
dc.publisher.url | http://dx.doi.org/10.1038/s41590-021-01084-z | |
dc.subject | Aged | |
dc.subject | Amino Acid Sequence | |
dc.subject | Antibodies, Viral | |
dc.subject | Antibody Affinity | |
dc.subject | COVID-19 | |
dc.subject | Cell Line, Transformed | |
dc.subject | Female | |
dc.subject | Gene Expression Profiling | |
dc.subject | HLA-B7 Antigen | |
dc.subject | Humans | |
dc.subject | Immunodominant Epitopes | |
dc.subject | Immunologic Memory | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Nucleocapsid Proteins | |
dc.subject | Receptors, Antigen, T-Cell | |
dc.subject | SARS-CoV-2 | |
dc.subject | Severity of Illness Index | |
dc.subject | T-Lymphocytes, Cytotoxic | |
dc.subject | Vaccinia virus | |
dc.title | An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease. | |
dc.type | Article | |
dcterms.dateAccepted | 2021-10-26 | |
prism.endingPage | 61 | |
prism.issueIdentifier | 1 | |
prism.publicationName | Nat Immunol | |
prism.startingPage | 50 | |
prism.volume | 23 | |
pubs.funder-project-id | Wellcome Trust (090315/Z/09/Z) | |
rioxxterms.licenseref.uri | http://creativecommons.org/licenses/by/4.0/ | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.1038/s41590-021-01084-z |
Files
Original bundle
1 - 5 of 6
Loading...
- Name:
- 41590_2021_1084_MOESM1_ESM.pdf
- Size:
- 411.94 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version
- Licence
- http://creativecommons.org/licenses/by/4.0/
No Thumbnail Available
- Name:
- additional-files.zip
- Size:
- 1.19 MB
- Format:
- ZIP file
- Description:
- Supporting information
- Licence
- http://creativecommons.org/licenses/by/4.0/
Loading...
- Name:
- 41590_2021_1084_MOESM3_ESM.pdf
- Size:
- 924.02 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version
- Licence
- http://creativecommons.org/licenses/by/4.0/
Loading...
- Name:
- 41590_2021_1084_MOESM2_ESM.pdf
- Size:
- 3.52 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version
- Licence
- http://creativecommons.org/licenses/by/4.0/
Loading...
- Name:
- 41590_2021_Article_1084.pdf
- Size:
- 11.68 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version
- Licence
- http://creativecommons.org/licenses/by/4.0/